50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Poverty and inflation: Egypt's economy hit by global turmoil
Germany secures more gas shipments as Scholz visits Gulf
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Poverty and inflation: Egypt's economy hit by global turmoil
Germany secures more gas shipments as Scholz visits Gulf
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Poverty and inflation: Egypt's economy hit by global turmoil
Germany secures more gas shipments as Scholz visits Gulf
S&P 500   3,693.23
DOW   29,590.41
QQQ   275.51
Get 1TB of Top-Rated Cloud Storage for Life for Just $112
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Saudi Arabia's triumphant week reclaims the West's embrace
Poverty, inflation, fear: Egypt's economy pushed to brink
Sell every Stock except ONE (Ad)
Labour conference starts with focus on 'immoral' tax cuts
German leader continues Gulf tour with stops in UAE, Qatar
Sell every Stock except ONE (Ad)
Poverty and inflation: Egypt's economy hit by global turmoil
Germany secures more gas shipments as Scholz visits Gulf
OTCMKTS:HDII

Hypertension Diagnostics - HDII Stock Forecast, Price & News

$0.0043
0.00 (0.00%)
(As of 09/23/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.0028
$0.0043
50-Day Range
N/A
52-Week Range
$0.00
$0.03
Volume
100,550 shs
Average Volume
72,233 shs
Market Capitalization
$916,287.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Hypertension Diagnostics

Hypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.

Receive HDII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hypertension Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

HDII Stock News Headlines

Hypertension Diagnostics Inc
Hypertension Diagnostics, Inc. (HDII)
News for Hypertension Diagnostics Inc
HDII After-Hours Quotes
HDII Pre-Market Quotes
HDII Real-Time Quotes
Hypertension Diagnostics Inc.
HYPERTENSION DIAGNOSTICS Inc., "HDII" Shareholder Update.
See More Headlines
Receive HDII Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hypertension Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

HDII Company Calendar

Today
9/25/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:HDII
CUSIP
44914V104
Employees
2,017
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
127,853,000
Market Cap
$916,287.00
Optionable
Not Optionable
Beta
-1.66

Key Executives

  • Liangjian Peng
    Chief Exec. Officer
  • Mr. Joseph D'Albero
    Exec.
  • Mr. Maury Taylor
    Exec. Director













HDII Stock - Frequently Asked Questions

How have HDII shares performed in 2022?

Hypertension Diagnostics' stock was trading at $0.0077 at the beginning of 2022. Since then, HDII stock has decreased by 43.8% and is now trading at $0.0043.
View the best growth stocks for 2022 here
.

What other stocks do shareholders of Hypertension Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hypertension Diagnostics investors own include Victory Square Technologies (VSQTF), Eyenovia (EYEN), ProShares UltraShort Oil & Gas (DUG), Cypress Semiconductor (CY), Celldex Therapeutics (CLDX), Century Aluminum (CENX), Black Diamond Therapeutics (BDTX), BioCryst Pharmaceuticals (BCRX) and

What is Hypertension Diagnostics' stock symbol?

Hypertension Diagnostics trades on the OTCMKTS under the ticker symbol "HDII."

How do I buy shares of Hypertension Diagnostics?

Shares of HDII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hypertension Diagnostics' stock price today?

One share of HDII stock can currently be purchased for approximately $0.00.

How much money does Hypertension Diagnostics make?

Hypertension Diagnostics (OTCMKTS:HDII) has a market capitalization of $916,287.00.

How many employees does Hypertension Diagnostics have?

The company employs 2,017 workers across the globe.

How can I contact Hypertension Diagnostics?

Hypertension Diagnostics' mailing address is 550 Highway 7 East Unit 316, Minnesota MN, L4B 3Z4. The official website for the company is www.hypertensiondiagnostics.com. The company can be reached via phone at (407) 449-6151 or via fax at 651-687-0485.

This page (OTCMKTS:HDII) was last updated on 9/25/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.